http://jcps.bjmu.edu.cn

中国药学(英文版) ›› 2024, Vol. 33 ›› Issue (11): 1099-1100.

• 【新闻】 • 上一篇    

北京大学王坚成团队/中日友好医院代华平团队提出了纳米药物通过线粒体通透性转换孔开放的“双刹”策略治疗特发性肺纤维化

北京大学药学院天然药物及仿生药物全国重点实验室   

  1. 北京大学药学院天然药物及仿生药物全国重点实验室
  • 收稿日期:2024-11-25 修回日期:2024-11-25 接受日期:2024-11-25 出版日期:2024-12-10 发布日期:2024-12-08

The research teams of Prof. Jiancheng Wang and Prof. Huaping Dai proposed a “Double Braking” strategy of nanomedicine on mitochondrial permeability transition pore for treating idiopathic pulmonary fibrosis

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center   

  1. State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center
  • Received:2024-11-25 Revised:2024-11-25 Accepted:2024-11-25 Online:2024-12-10 Published:2024-12-08

摘要:

2024年10月30日, 北京大学药学院天然药物及仿生药物全国重点实验室王坚成团队和中日友好医院代华平团队在国际著名期刊Advanced Science在线刊登了基于调控线粒体开放改善特发性肺纤维化治疗的最新研究成果“Double Braking Effects of Nanomedicine on Mitochondrial Permeability Transition Pore for Treating Idiopathic Pulmonary Fibrosis”(纳米粒子对线粒体通透性转换孔的“双刹”效应治疗特发性肺纤维化)。

Abstract: The research teams of Prof. Jiancheng Wang and Prof. Huaping Dai proposed a “Double Braking” strategy of nanomedicine on mitochondrial permeability transition pore for treating idiopathic pulmonary fibrosis

Supporting: